Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;51(5):440-444.
doi: 10.1016/j.idnow.2021.03.004. Epub 2021 Mar 22.

Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study

L Cousyn  1 , B Sellem  2 , R Palich  3 , D Bendetowicz  4 , R Agher  3 , C Delorme  5 , R Tubiana  3 , M-A Valantin  3 , S Seang  3 , L Schneider  3 , A Fayçal  2 , Y Dudoit  3 , B Abdi  6 , A Ndoadoumgue  7 , L Assoumou  7 , C Katlama  3 ; COVIDOM-19 PSL group
Affiliations

Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study

L Cousyn et al. Infect Dis Now. 2021 Aug.

Abstract

Objectives: To describe the characteristics, evolution and risk factors for long-term persistence of olfactory and gustatory dysfunctions (OGD) in COVID-19 outpatients.

Patients and methods: We conducted a prospective study in SARS-CoV-2 infected outpatients with OGD. Weekly phone interviews were set up starting from COVID-19 onset symptoms and over the course of 60 days, using standardized questionnaires that included a detailed description of general symptoms and OGD. The primary outcome was the proportion of patients with complete recovery of OGD at D30. Rate and time to recovery of OGD, as well as risk factors for late recovery (>30 days), were evaluated using Cox regression models.

Results: Ninety-eight outpatients were included. The median time to onset of OGD after first COVID-19 symptoms was 2 days (IQR 0-4). The 30-day recovery rate from OGD was 67.5% (95% CI 57.1-75.4) and the estimated median time of OGD recovery was 20 days (95% CI 13-26). Risk factors for late recovery of OGD were a complete loss of smell or taste at diagnosis (HR=0.26, 95% CI 0.12-0.56, P=0.0005) and age over 40 years (HR=0.56, 95% CI 0.36-0.89, P=0.01).

Conclusions: COVID-19 patients with complete loss of smell or taste and over age 40 are more likely to develop persistent OGD and should rapidly receive sensorial rehabilitation.

Keywords: Ageusia; Anosmia; SARS-CoV-2; Smell; Taste.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Evolution and recovery of OGD over time. A. Olfactory dysfunction. B. Gustatory dysfunction. C. Cumulated olfactory and gustatory dysfunctions.
See this image and copyright information in PMC

References

    1. Welge-Lüssen A., Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol. 2006;63:125–132. doi: 10.1159/000093758. - DOI - PubMed
    1. Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 doi: 10.1007/s00405-020-05965-1. - DOI - PMC - PubMed
    1. Agyeman A.A., Chin K.L., Landersdorfer C.B., Liew D., Ofori-Asenso R. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95:1621–1631. doi: 10.1016/j.mayocp.2020.05.030. - DOI - PMC - PubMed
    1. Tong J.Y., Wong A., Zhu D., Fastenberg J.H., Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis: otolaryngology. Head Neck Surg. 2020 doi: 10.1177/0194599820926473. - DOI - PubMed
    1. Beltrán-Corbellini Á., Chico-García J.L., Martínez-Poles J., Rodríguez-Jorge F., Natera-Villalba E., Gómez-Corral J., et al. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case–control study. Eur J Neurol. 2020;27:1738–1741. doi: 10.1111/ene.14273. - DOI - PMC - PubMed